Navigation Links
Neogen Develops Quickest Single Test for Beta-Lactams and Tetracyclines in Milk
Date:4/27/2009

LANSING, Mich., April 27 /PRNewswire-FirstCall/ -- Neogen Corporation (Nasdaq: NEOG) has expanded its line of products developed for the worldwide dairy industry to include the quickest single test available to simultaneously detect beta-lactam and tetracycline antibiotic residues in milk.

Developed to comply with the European Union's maximum residue levels, Neogen's new BetaStar(R) Combo utilizes the same format as the popular BetaStar assay -- an extremely easy lateral flow test that requires only minimal training and equipment to produce consistently accurate results. At just 5 minutes, BetaStar Combo is the fastest assay for beta-lactams and tetracyclines in a single test.

"As the use of both tetracycline and beta-lactam antibiotics for the management of mastitis in dairy herds has grown in certain regions of the world, the need for a single test to simultaneously detect both groups of antibiotics has also grown," said Ed Bradley, Neogen's vice president of Food Safety. "Developing BetaStar Combo allows us to offer the worldwide dairy industry yet another simple solution to protect its consumers and businesses. Neogen can now offer the dairy industry rapid, easy tests to detect either beta-lactam or tetracycline antibiotics, or both at the same time, in the same simple test format."

The BetaStar Combo test method is easy to use and is also very rugged -- making the test effective for use in the milk receiving laboratory, on the truck, or even at the farm level.

The tetracycline group of antibiotics is not as widely used as the beta-lactam group; therefore, testing for tetracycline residues in milk is not as widespread. The European Union has set a maximum residue level of 100 parts per billion for tetracyclines in milk and Neogen expects the strongest initial interest for its BetaStar Combo product from EU countries, where tetracyclines are more widely used for treatment of mastitis.

Earlier this year, Neogen received approval from the FDA and National Conference on Interstate Milk Shipments (NCIMS) for its quick and easy BetaStar(R)US test for dairy antibiotics in milk. This approval allows milk producers and processors in the United States to use Neogen's new test to comply with FDA regulations that require the mandatory testing of milk for dairy antibiotics. BetaStar US had previously earned an important approval from the AOAC Research Institute (AOAC-RI No. 030802) after rigorous testing.

Neogen Corporation develops and markets products dedicated to food and animal safety. The company's Food Safety Division markets dehydrated culture media, and diagnostic test kits to detect foodborne bacteria, natural toxins, genetic modifications, food allergens, drug residues, plant diseases and sanitation concerns. Neogen's Animal Safety Division markets a complete line of diagnostics, veterinary instruments, veterinary pharmaceuticals, nutritional supplements, disinfectants, and rodenticides.


'/>"/>
SOURCE Neogen Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Neogen Reports Record Third Quarter
2. Webcast Alert: Neogen Corporation Announces 3rd Quarter Results Conference Call
3. NeoGenomics Announces Fourth Quarter and Full Year 2008 Financial Results
4. NeoGenomics Schedules its Q4 and Full Year 2008 Earnings Release for March 5, 2009
5. Neogen Names New Senior Science Officer; Added to S&P Index
6. Neogen Named Supplier of Chr. Hansen Probiotics for Swine and Poultry
7. Neogens BetaStar(R) US Dairy Antibiotic Test Approved by FDA/NCIMS
8. Neogen Reports Best Quarter in Its 26-Year History
9. Neogen Announces New Share Repurchase Program
10. NeoGenomics to Present at the Rodman & Renshaw Healthcare Conference on November 10
11. Neogen Honored by Forbes; Two Brokerage Firms Initiate Coverage
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... ... ... The Pittcon Organizing Committee is pleased to announce that Charles “Chuck” Gardner was named ... 1987. Since then, he has served in a number of key leadership positions including ... program and exposition committees. In his professional career, Dr. Gardner is the director of ...
(Date:4/27/2016)... ... April 27, 2016 , ... The ... announce the appointment of John Tilton as Chief Commercial Officer.  Mr. Tilton joined ... of the founding commercial leaders responsible for the commercialization of multiple orphan drug ...
(Date:4/27/2016)... ... ... Global Stem Cells Group CEO Benito Novas announced that Duncan Ross, ... Kimera Labs in Miami. , In 2004, Ross received his Ph.D. in Immunology from ... and the suppression of graft vs. host disease (GVHD) under UM Professor Robert Levy ...
(Date:4/26/2016)... ... April 27, 2016 , ... ... Rothgerber Christie LLP as an associate in the firm’s Intellectual Property practice group. ... mechanical and electromechanical patent applications. He has an electrical engineering and computer engineering ...
Breaking Biology Technology:
(Date:3/29/2016)... LegacyXChange, Inc. (OTC: LEGX ... Protect are pleased to announce our successful effort to ... of writing instruments, ensuring athletes signatures against counterfeiting and ... athletes on LegacyXChange will be assured of ongoing proof ... Bill Bollander , CEO states, "By inserting ...
(Date:3/18/2016)... 18, 2016 --> ... ICT, Manned & Unmanned Vehicles, Physical infrastructure and Perimeter Surveillance ... in the border security market and the continuing migration crisis ... Europe has led visiongain to publish this ... --> defence & security companies in the ...
(Date:3/14/2016)... Allemagne, March 14, 2016 ... - --> - Renvoi : image disponible ... --> --> DERMALOG, ... fournit de nouveaux lecteurs d,empreintes digitales pour l,enregistrement ... DERMALOG sera utilisé pour produire des cartes d,identité ...
Breaking Biology News(10 mins):